Investment Management Corp of Ontario (IMCO)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,268
Closed -$263K 661
2025
Q1
$263K Sell
9,268
-15,278
-62% -$542K 0.01% 627
2024
Q4
$1.02M Buy
24,546
+13,678
+126% +$654K 0.03% 234
2024
Q3
$726K Buy
10,868
+3,600
+50% +$331K 0.02% 451
2024
Q2
$863K Buy
7,268
+2,000
+38% +$253K 0.02% 356
2024
Q1
$561K Sell
5,268
-2,300
-30% -$232K 0.02% 398
2023
Q4
$753K Buy
+7,568
New +$637K 0.02% 396

Other funds holding MRNA

Investment Management Corp of Ontario (IMCO)'s MRNA Position: Q2 2025 in Review

Investment Management Corp of Ontario (IMCO) sold out of Moderna (MRNA) in Q2 2025, closing a stake of 9,268 shares — an estimated $263K sold.

Investment Management Corp of Ontario (IMCO) first reported a position in MRNA in Q4 2023 and held it in 6 quarters. The position peaked at $1.02M in Q4 2024. 675 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Investment Management Corp of Ontario (IMCO) reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Investment Management Corp of Ontario (IMCO) sold 9,268 Moderna shares in Q2 2025, an estimated $263K.
  • Investment Management Corp of Ontario (IMCO) first reported a position in Moderna in Q4 2023 and held it in 6 quarters.
  • Investment Management Corp of Ontario (IMCO)'s Moderna position peaked at $1.02M in Q4 2024.
  • 675 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Investment Management Corp of Ontario (IMCO)'s 13F filing for Q2 2025, filed 14 Aug 2025.